{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:45:59Z","timestamp":1791895559259,"version":"4.3.4"},"reference-count":60,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ekir.2024.07.008","type":"journal-article","created":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T21:38:49Z","timestamp":1721252329000},"page":"2956-2969","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Lower Parathyroid Hormone Levels are Associated With Reduced Fracture Risk in Japanese Patients on Hemodialysis"],"prefix":"10.1016","volume":"9","author":[{"given":"Hirotaka","family":"Komaba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Hamano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiko","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Hanafusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Fukagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2024.07.008_bib1","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2215\/CJN.12941213","article-title":"Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study","volume":"10","author":"Tentori","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2024.07.008_bib2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12882-018-1056-5","article-title":"Mineral and bone disorder management in hemodialysis patients: comparing PTH control practices in Japan with Europe and North America: the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"19","author":"Yamamoto","year":"2018","journal-title":"BMC Nephrol"},{"issue":"7","key":"10.1016\/j.ekir.2024.07.008_bib3","first-page":"1","article-title":"KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","year":"2017","journal-title":"Kidney Int Suppl (2011)"},{"key":"10.1016\/j.ekir.2024.07.008_bib4","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1744-9987.2008.00648.x","article-title":"Clinical practice guideline for the management of secondary hyperparathyroidism in chronic dialysis patients","volume":"12","year":"2008","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.ekir.2024.07.008_bib5","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJM199507203330307","article-title":"Renal osteodystrophy","volume":"333","author":"Hruska","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2024.07.008_bib6","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1359\/jbmr.1998.13.8.1213","article-title":"A\u00a0structural approach to renal bone disease","volume":"13","author":"Parfitt","year":"1998","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.ekir.2024.07.008_bib7","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/jbmr.1916","article-title":"Rapid cortical bone loss in patients with chronic kidney disease","volume":"28","author":"Nickolas","year":"2013","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.ekir.2024.07.008_bib8","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1159\/000489671","article-title":"Deterioration of cortical bone microarchitecture: critical component of renal osteodystrophy evaluation","volume":"47","author":"Sharma","year":"2018","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.ekir.2024.07.008_bib9","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/jbmr.5650110921","article-title":"Prediction of fracture load at different skeletal sites by geometric properties of the cortical shell","volume":"11","author":"Augat","year":"1996","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.ekir.2024.07.008_bib10","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.bone.2003.06.003","article-title":"Mechanical consequences of different scenarios for simulated bone atrophy and recovery in the distal radius","volume":"33","author":"Pistoia","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.ekir.2024.07.008_bib11","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/ki.2008.60","article-title":"Adynamic bone in patients with chronic kidney disease","volume":"73","author":"Andress","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2024.07.008_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/ndt\/11.supp3.111","article-title":"Trends in renal osteodystrophy: a survey from 1983 to 1995 in a total of 2248 patients","volume":"11","author":"Monier-Faugere","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2024.07.008_bib13","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1046\/j.1523-1755.63.s85.13.x","article-title":"The renal osteodystrophy pattern in Brazil and Uruguay: an overview","author":"Ara\u00fajo","year":"2003","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.ekir.2024.07.008_bib14","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, andmorbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2024.07.008_bib15","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/sj.ki.5001754","article-title":"Incidence and risk factors for hip orother bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study","volume":"70","author":"Jadoul","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2024.07.008_bib16","doi-asserted-by":"crossref","unstructured":"Barrera-Baena P, Rodr\u00edguez-Garc\u00eda M, Rodr\u00edguez-Rubio E, et\u00a0al. Serum phosphate is associated with increased risk of bone fragility fractures in hemodialysis patients. Nephrol Dial Transplant. 39:618-626. https:\/\/doi.org\/10.1093\/ndt\/gfad190","DOI":"10.1093\/ndt\/gfad190"},{"key":"10.1016\/j.ekir.2024.07.008_bib17","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1046\/j.1523-1755.2003.00073.x","article-title":"Pharmacokinetics of oral micronized beta-estradiol in postmenopausal women receiving maintenance hemodialysis","volume":"64","author":"Stehman-Breen","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2024.07.008_bib18","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.bone.2006.09.017","article-title":"Age and sex are sufficient for predicting fractures occurring within 1 year of hemodialysis treatment","volume":"40","author":"Mitterbauer","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.ekir.2024.07.008_bib19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.ajkd.2005.09.024","article-title":"PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis","volume":"47","author":"Danese","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2024.07.008_bib20","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1053\/ajkd.2000.19812","article-title":"Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone","volume":"36","author":"Coco","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2024.07.008_bib21","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.2215\/CJN.09280915","article-title":"Bone parameters and risk of hip and femur fractures in patients on hemodialysis","volume":"11","author":"Fishbane","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2024.07.008_bib22","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/jbmr.309","article-title":"Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients","volume":"26","author":"Malluche","year":"2011","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.ekir.2024.07.008_bib23","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/jama.2016.19468","article-title":"Effect of etelcalcetide vs Cinacalcet on serum parathyroid hormone in patients receiving hemodialysis with secondary hyperparathyroidism: a randomized clinical trial","volume":"317","author":"Block","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.ekir.2024.07.008_bib24","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.kint.2018.05.013","article-title":"Head-to-head comparison of the new calcimimetic agent evocalcet with Cinacalcet in Japanese hemodialysis patients with secondary hyperparathyroidism","volume":"94","author":"Fukagawa","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2024.07.008_bib25","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.2215\/CJN.0000000000000253","article-title":"Efficacy and safety of upacicalcet in hemodialysis patients with secondary hyperparathyroidism: a randomized placebo-controlled trial","volume":"18","author":"Shigematsu","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2024.07.008_bib26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s41100-018-0183-6","article-title":"Annual dialysis data report 2016, JSDT Renal Data Registry","volume":"4","author":"Masakane","year":"2018","journal-title":"Ren Replace Ther"},{"key":"10.1016\/j.ekir.2024.07.008_bib27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s41100-019-0248-1","article-title":"Annual dialysis data report 2017, JSDT Renal Data Registry","volume":"5","author":"Nitta","year":"2019","journal-title":"Ren Replace Ther"},{"key":"10.1016\/j.ekir.2024.07.008_bib28","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/bmj.4.5893.643","article-title":"Interpretation of serum calcium in patients with abnormal serum proteins","volume":"4","author":"Payne","year":"1973","journal-title":"BMJ"},{"key":"10.1016\/j.ekir.2024.07.008_bib29","series-title":"Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis","author":"Harrell","year":"2001"},{"key":"10.1016\/j.ekir.2024.07.008_bib30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jclinepi.2008.11.004","article-title":"Absolute risk reductions, relative risks, relative risk reductions, and numbers needed to treat can be obtained from a logistic regression model","volume":"63","author":"Austin","year":"2010","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.ekir.2024.07.008_bib31","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0895-4356(01)00510-8","article-title":"Calculating the \u201cnumber needed to be exposed\u201d with adjustment for confounding variables in epidemiological studies","volume":"55","author":"Bender","year":"2002","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.ekir.2024.07.008_bib32","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.ekir.2024.01.002","article-title":"Alkaline phosphatase and parathyroid hormone levels: international variation and associations with clinical outcomes in the DOPPS","volume":"9","author":"Yamamoto","year":"2024","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ekir.2024.07.008_bib33","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/ki.2008.248","article-title":"High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and death","volume":"74","author":"Blayney","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2024.07.008_bib34","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1093\/ndt\/gfu055","article-title":"A\u00a0higher serum alkaline phosphatase is associated with the incidence of hip fracture and mortality among patients receiving hemodialysis in Japan","volume":"29","author":"Maruyama","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2024.07.008_bib35","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1053\/j.ajkd.2013.02.366","article-title":"Bone alkaline phosphatase in CKD-mineral bone disorder","volume":"62","author":"Sardiwal","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2024.07.008_bib36","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1681\/ASN.2014040414","article-title":"Effects of Cinacalcet on fracture events in patients receiving hemodialysis: the EVOLVE trial","volume":"26","author":"Moe","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2024.07.008_bib37","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s00774-024-01500-y","article-title":"Effectiveness of calcimimetics on fractures in dialysis patients with secondary hyperparathyroidism: meta-analysis of randomized trials","volume":"42","author":"Wakamatsu","year":"2024","journal-title":"J\u00a0Bone Miner Metab"},{"key":"10.1016\/j.ekir.2024.07.008_bib38","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1681\/ASN.2007010022","article-title":"Fracture risk after parathyroidectomy among chronic hemodialysis patients","volume":"18","author":"Rudser","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2024.07.008_bib39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/ndt\/gfv291","article-title":"Changes in secondary hyperparathyroidism-related biochemical parameters and medication use following parathyroidectomy","volume":"31","author":"Wetmore","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2024.07.008_bib40","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/ndt\/gfr317","article-title":"Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients-a single-center cohort study","volume":"27","author":"Iimori","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2024.07.008_bib41","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.kint.2020.02.035","article-title":"Metacarpal bone mineral density by radiographic absorptiometry predicts fracture risk in patients undergoing maintenance hemodialysis","volume":"98","author":"Nakagawa","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2024.07.008_bib42","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqad022","article-title":"Evocalcet rescues secondary hyperparathyroidism-driven cortical porosity in CKD male rats","volume":"164","author":"Hasegawa","year":"2023","journal-title":"Endocrinology"},{"key":"10.1016\/j.ekir.2024.07.008_bib43","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cmet.2015.11.003","article-title":"PTH\/PTHrP receptor mediates cachexia in models of kidney failure and cancer","volume":"23","author":"Kir","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.ekir.2024.07.008_bib44","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/jcsm.12722","article-title":"Secondary hyperparathyroidism, weight loss, and longer term mortality in haemodialysis patients: results from the DOPPS","volume":"12","author":"Komaba","year":"2021","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ekir.2024.07.008_bib45","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10157-016-1369-2","article-title":"Management of secondary hyperparathyroidism: how and why?","volume":"21","author":"Komaba","year":"2017","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.ekir.2024.07.008_bib46","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1007\/s00198-011-1890-9","article-title":"Evaluation of bone microarchitecture by high-resolution peripheral quantitative computed tomography (HR-pQCT) in hemodialysis patients","volume":"23","author":"Negri","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ekir.2024.07.008_bib47","doi-asserted-by":"crossref","DOI":"10.2215\/CJN.0000000000000254","article-title":"Changes in bone quality after treatment with etelcalcetide","volume":"18","author":"Khairallah","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2024.07.008_bib48","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00774-014-0582-x","article-title":"Efficacy and safety of eldecalcitol, a new active vitamin D3 analog, in the bone metabolism of postmenopausal women receiving maintenance hemodialysis","volume":"33","author":"Sasaki","year":"2015","journal-title":"J\u00a0Bone Miner Metab"},{"key":"10.1016\/j.ekir.2024.07.008_bib49","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1055\/s-2003-39483","article-title":"Effect of parathyroidectomy on bone mineral density in hemodialysis patients with secondary hyperparathyroidism: possible usefulness of preoperative determination of parathyroid hormone level for prediction of bone regain","volume":"35","author":"Yano","year":"2003","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.ekir.2024.07.008_bib50","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1053\/ajkd.2002.34519","article-title":"PTH 1\u201384 and PTH \u20187\u201384\u2019 in the noninvasive diagnosis of renal bone disease","volume":"40","author":"Coen","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2024.07.008_bib51","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/ndt\/gfg144","article-title":"Influence of PTH assay methodology on differential diagnosis of renal bone disease","volume":"18","author":"Reichel","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2024.07.008_bib52","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1046\/j.1523-1755.2001.00949.x","article-title":"Improved assessment of bone turnover by the PTH-(1\u201384)\/large C-PTH fragments ratio in ESRD patients","volume":"60","author":"Monier-Faugere","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2024.07.008_bib53","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1681\/ASN.2022010036","article-title":"High-resolution mass spectrometry for the measurement of PTH and PTH fragments: insights into PTH physiology and bioactivity","volume":"33","author":"Ulmer","year":"2022","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2024.07.008_bib54","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0085-2538(15)47156-X","article-title":"A\u00a0novel mechanism for skeletal resistance in uremia","volume":"58","author":"Slatopolsky","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2024.07.008_bib55","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S8756-3282(00)00346-X","article-title":"Inorganic phosphate induces apoptosis of osteoblast-like cells in culture","volume":"27","author":"Meleti","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.ekir.2024.07.008_bib56","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/jcp.10270","article-title":"Effect of a high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity","volume":"196","author":"Kanatani","year":"2003","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.ekir.2024.07.008_bib57","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1681\/ASN.2021111493","article-title":"Differences in phosphate and parathyroid hormone concentrations over the day among patients on hemodialysis","volume":"33","author":"Ginsberg","year":"2022","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2024.07.008_bib58","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1681\/ASN.V1341017","article-title":"The calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism","volume":"13","author":"Goodman","year":"2002","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2024.07.008_bib59","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.kint.2018.12.015","article-title":"Calcimimetics maintain bone turnover in uremic rats despite the concomitant decrease in parathyroid hormone concentration","volume":"95","author":"D\u00edaz-Tocados","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2024.07.008_bib60","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/jbmr.4913","article-title":"Active vitamin D use and fractures in hemodialysis patients: results from the international DOPPS","volume":"38","author":"Komaba","year":"2023","journal-title":"J\u00a0Bone Miner Res"}],"updated-by":[{"DOI":"10.1016\/j.ekir.2025.05.010","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000}}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024924018242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024924018242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T04:17:25Z","timestamp":1732421845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024924018242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":60,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2468024924018242"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2024.07.008","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lower Parathyroid Hormone Levels are Associated With Reduced Fracture Risk in Japanese Patients on Hemodialysis","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2024.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2024.08.023","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}